G
Galera Therapeutics (GRTX)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Galera Therapeutics (GRTX)
Galera Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing a pipeline of therapeutic candidates to transform radiotherapy in cancer. Its lead product candidate, avasopasem mangane... Read more
- USD0.16
- USD0.17
- USD0.14
- USD3.59
- -38.00%
- --
- 871.00
- 1.64M
- 12M
- 0.09
- -96.40%
Stock News
1 hour ago
Alexandria Real Estate Equities, Inc. Declares Cash Dividend of $1.32 per Common Share for 2Q25
Yahoo
1 hour ago
Steel stocks surge after Trump doubles steel tariffs, Cleveland Cliffs jumps 25%
CNBC
1 hour ago
People are dining out less. That’s a boost to the Campbell’s meals-at-home business.
MarketWatch
1 hour ago
4-time NBA champion Stephen Curry says even he suffers from impostor syndrome
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
